Nxera Pharma Co Ltd (SOLTF)
9.304
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Nxera Pharma Cash from Investing (Quarterly): -18.93M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.93M |
| September 30, 2023 | -422.97M |
| June 30, 2023 | -11.78M |
| March 31, 2023 | -0.9842M |
| December 31, 2022 | 8.462M |
| September 30, 2022 | 0.949M |
| June 30, 2022 | -0.6376M |
| March 31, 2022 | -0.7747M |
| December 31, 2021 | -0.9096M |
| September 30, 2021 | -0.3024M |
| June 30, 2021 | 4.331M |
| March 31, 2021 | -0.5854M |
| December 31, 2020 | -0.3783M |
| September 30, 2020 | 2.569M |
| June 30, 2020 | -5.414M |
| March 31, 2020 | 1.818M |
| December 31, 2019 | -0.2527M |
| September 30, 2019 | 0.7796M |
| June 30, 2019 | -0.8681M |
| March 31, 2019 | -1.916M |
| September 30, 2018 | -8.494M |
| June 30, 2018 | -8.903M |
| March 31, 2018 | -4.984M |
| December 31, 2017 | -4.732M |
| September 30, 2017 | 0.7415M |
| Date | Value |
|---|---|
| June 30, 2017 | -46.51M |
| March 31, 2017 | -2.907M |
| December 31, 2016 | -16.37M |
| September 30, 2016 | -1.052M |
| June 30, 2016 | -1.185M |
| March 31, 2016 | -0.8738M |
| December 31, 2015 | -0.8378M |
| September 30, 2015 | -0.4537M |
| June 30, 2015 | -0.643M |
| March 31, 2015 | -197.79M |
| December 31, 2014 | -2.154M |
| September 30, 2014 | -0.6411M |
| June 30, 2014 | -0.7636M |
| March 31, 2014 | -1.304M |
| December 31, 2013 | -0.6715M |
| September 30, 2013 | -0.5525M |
| June 30, 2013 | -0.6193M |
| March 31, 2011 | -0.0368M |
| December 31, 2010 | -0.4614M |
| September 30, 2010 | 0.1847M |
| June 30, 2010 | 0.00 |
| March 31, 2010 | -0.1118M |
| December 31, 2009 | 0.0143M |
| September 30, 2009 | 0.3526M |
| June 30, 2009 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-422.97M
Minimum
Sep 2023
8.462M
Maximum
Dec 2022
-23.47M
Average
-0.5854M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -460.58M |
| PeptiDream Inc | -3.046M |
| Stemcell Holdings Inc | -0.1868M |
| Healios KK | -0.8731M |
| AnGes Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.804M |
| Cash from Financing (Quarterly) | 70.34M |
| Free Cash Flow | -43.65M |
| Free Cash Flow Per Share (Quarterly) | -0.1113 |
| Free Cash Flow to Equity (Quarterly) | -42.52M |
| Free Cash Flow to Firm (Quarterly) | -8.676M |
| Free Cash Flow Yield | -5.69% |